Summary
Human abuse potential (HAP) studies are conducted to determine the potential abuse of a drug that has rewarding properties. Abuse potential refers to the likelihood for a drug to be used in nonmedical situations for its positive psychoactive effects, eg, euphoria, hallucinations and mood changes. This poster considers subject selection and a study conducted by PRA Health Sciences to assess whether there were common cognitive and psychological characteristics of subjects who passed or failed the discrimination phase of a HAP study.
Register to download
Select Characteristics of Recreational Opioid Users Undergoing a Human Abuse Potential Study
You may also be interested in:
Fact Sheet
Vaccine Solutions
PRA’s Vaccine Solutions group understands the unique challenges and characteristics of vaccine development. Right from the start, our experts will…
Fact Sheet
First-in-Human Drug Evaluation at PRA Health Sciences & The Revised EMA Guideline on Early Clinical Trials
In July 2017, the European Medicines Agency (EMA) published its revised guidance on first-in-human (FIH) and early clinical trials. The revision…
White Paper
Human ADME Studies With Radiolabeled Compounds Phase I-IIa
Radiolabeled medication is widely used in the assessment of human ADME and also increasingly in assessing absolute bioavailability (BA). Conducting…